Cargando…

Kinetics of Microbial Translocation Markers in Patients on Efavirenz or Lopinavir/r Based Antiretroviral Therapy

OBJECTIVES: We investigated whether there are differences in the effects on microbial translocation (MT) and enterocyte damage by different antiretroviral therapy (ART) regimens after 1.5 years and whether antibiotic use has impact on MT. In a randomized clinical trial (NCT01445223) on first line AR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vesterbacka, Jan, Nowak, Piotr, Barqasho, Babilonia, Abdurahman, Samir, Nyström, Jessica, Nilsson, Staffan, Funaoka, Hiroyuki, Kanda, Tatsuo, Andersson, Lars-Magnus, Gisslèn, Magnus, Sönnerborg, Anders
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557242/ https://www.ncbi.nlm.nih.gov/pubmed/23383047 http://dx.doi.org/10.1371/journal.pone.0055038

Ejemplares similares

Pattern of microbial translocation in patients living with HIV-1 from Vietnam, Ethiopia and Sweden
por: Abdurahman, Samir, et al.
Publicado: (2014)

Microbial Translocation Contribute to Febrile Episodes in Adults with Chemotherapy-Induced Neutropenia
por: Wong, Michelle, et al.
Publicado: (2013)

Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA levels
por: Sörstedt, Erik, et al.
Publicado: (2016)

Lopinavir/r + Efavirenz combination as a potent NRTI sparing antiretroviral therapy
por: Henrivaux, Philippe, et al.
Publicado: (2010)

Altered Gut Microbiome under Antiretroviral Therapy: Impact of Efavirenz and Zidovudine
por: Ray, Shilpa, et al.
Publicado: (2020)

Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy-years
por: Lima, Viviane D, et al.
Publicado: (2014)

Efavirenz and Lopinavir/Ritonavir Alter Cell Cycle Regulation in Lung Cancer
por: Marima, Rahaba, et al.
Publicado: (2020)

Effect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected patients
por: Häggblom, Amanda, et al.
Publicado: (2017)

Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4(+) T-Cell Responses
por: Marklund, Emelie, et al.
Publicado: (2021)

Serum neopterin levels in relation to mild and severe COVID-19
por: Robertson, Josefina, et al.
Publicado: (2020)

Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection
por: Anesten, Birgitta, et al.
Publicado: (2021)

Residual Central Nervous System Immune Activation Is Not Prevented by Antiretroviral Therapy Initiated During Early Chronic HIV Infection
por: Edén, Arvid, et al.
Publicado: (2023)

Correction: Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection
por: Anesten, Birgitta, et al.
Publicado: (2022)

Association between Plasma Homocysteine Levels and Neuronal Injury in HIV Infection
por: Ahlgren, Erika, et al.
Publicado: (2016)

The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?
por: Gisslén, Magnus, et al.
Publicado: (2011)

Efficacy and Tolerability of Lopinavir/Ritonavir- and Efavirenz-Based Initial Antiretroviral Therapy in HIV-1-Infected Patients in a Tertiary Care Hospital in Beijing, China
por: Su, Bin, et al.
Publicado: (2019)

Impact of Efavirenz-, Ritonavir-Boosted Lopinavir-, and Nevirapine-Based Antiretroviral Regimens on the Pharmacokinetics of Lumefantrine and Safety of Artemether-Lumefantrine in Plasmodium falciparum-Negative HIV-Infected Malawian Adults Stabilized on Antiretroviral Therapy
por: Banda, Clifford G., et al.
Publicado: (2018)

Rebound of residual plasma viremia after initial decrease following addition of intravenous immunoglobulin to effective antiretroviral treatment of HIV
por: Mellberg, Tomas, et al.
Publicado: (2011)

All-Cause Mortality and Serious Non-AIDS Events in Adults With Low-level Human Immunodeficiency Virus Viremia During Combination Antiretroviral Therapy: Results From a Swedish Nationwide Observational Study
por: Elvstam, Olof, et al.
Publicado: (2020)

Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders
por: Marklund, Emelie, et al.
Publicado: (2020)

Correction: Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders
por: Marklund, Emelie, et al.
Publicado: (2021)

Comparable endemic coronavirus nucleoprotein‐specific antibodies in mild and severe Covid‐19 patients
por: Leach, Susannah, et al.
Publicado: (2021)

The effect of vitamin B supplementation on neuronal injury in people living with HIV: a randomized controlled trial
por: Tyrberg, Erika, et al.
Publicado: (2022)

Risk of Cardiovascular Events Among Patients Initiating Efavirenz-Containing Versus Efavirenz-Free Antiretroviral Regimens
por: Rosenblatt, Lisa, et al.
Publicado: (2016)

Higher plasma drug levels in elderly people living with HIV treated with darunavir
por: Tyrberg, Erika, et al.
Publicado: (2021)

Factors associated with low-level viraemia in people with HIV starting antiretroviral therapy: A Swedish observational study
por: Brattgård, Hanna, et al.
Publicado: (2022)

Comparison of SARS-CoV-2 spike RNA sequences in feces and nasopharynx indicates intestinal replication
por: Beck-Friis, Thomas, et al.
Publicado: (2022)

Prediction of plasma efavirenz concentrations among HIV-positive patients taking efavirenz-containing combination antiretroviral therapy
por: Huang, Sung-Hsi, et al.
Publicado: (2017)

Reduction of the HIV-1 reservoir in resting CD4(+ )T-lymphocytes by high dosage intravenous immunoglobulin treatment: a proof-of-concept study
por: Lindkvist, Annica, et al.
Publicado: (2009)

Impact of HMGB1/TLR Ligand Complexes on HIV-1 Replication: Possible Role for Flagellin during HIV-1 Infection
por: Nowak, Piotr, et al.
Publicado: (2012)

‘Covering the tail’ after stopping efavirenz-based antiretroviral therapy
por: Maartens, Gary
Publicado: (2020)

Dyslipidemias and Elevated Cardiovascular Risk on Lopinavir-Based Antiretroviral Therapy in Cambodia
por: Limsreng, Setha, et al.
Publicado: (2016)

Antiretroviral treatment in HIV-1 infected pediatric patients: focus on efavirenz
por: Larru, Beatriz, et al.
Publicado: (2014)

Acute Liver Failure among Patients on Efavirenz-Based Antiretroviral Therapy
por: Segamwenge, Innocent Lule, et al.
Publicado: (2018)

Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up
por: Kanberg, Nelly, et al.
Publicado: (2021)

Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection
por: Gisslén, Magnus, et al.
Publicado: (2005)

Temporal Trends in the Swedish HIV-1 Epidemic: Increase in Non-B Subtypes and Recombinant Forms over Three Decades
por: Neogi, Ujjwal, et al.
Publicado: (2014)

Variability of efavirenz plasma concentrations among pediatric HIV patients treated with efavirenz based combination antiretroviral therapy in Dar es Salaam, Tanzania
por: Sungi, Selemani Saidi, et al.
Publicado: (2018)

Efavirenz Conceptions and Regimen Management in a Prospective Cohort of Women on Antiretroviral Therapy
por: Schwartz, Sheree, et al.
Publicado: (2012)

Drug resistance after cessation of efavirenz-based antiretroviral treatment started in pregnancy
por: Ajibola, Globahan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pcbiljj38v2nn409nse6dekb30